Julie

Votre espace se prépare…

Preparing your space…

Le chargement prend plus de temps que prévu.
Réessayer
Loading is taking longer than expected.
Try again
Skip to main content

Records · procedure · next step

Medical genetic laboratory: permission records

Medical genetic laboratory preparation connects the operator, site and analytical catalogue to actual permissions and competence records. France separates laboratory authorisation, accreditation and practitioner approval. Switzerland’s federal framework adds its own scope, outsourcing, change and activity-reporting rules. This register identifies missing or mismatched records without approving a laboratory, recognising qualifications, interpreting patient results or treating patient consent as the operator’s permission.

General information and document preparation. The facts, actual procedural acts and applicable versions must be checked.

Julie’s legal research currently covers French law. The Swiss sections prepare documents; they do not establish Swiss-law product capability.

Julie by AlphaDeep

Illustrative conversation
Example question

France: which holder, authority and site are distinguished?

Julie Illustration

L. 1131-2-1 addresses the laboratory/health-establishment holder; R. 1131-14 identifies ARS, analysis categories and exercise site. Record actual decisions rather than an internal department name.

Read the references

Which country and laboratory activity are involved? Julie’s legal research currently covers French law.

Law:
France / Switzerland

3 free questions at signup. Avoid names and sensitive information.

Laboratory-analysis-site and permission-scope matrix
Document questionReference and records to compare

France: which holder, authority and site are distinguished?

L. 1131-2-1 addresses the laboratory/health-establishment holder; R. 1131-14 identifies ARS, analysis categories and exercise site. Record actual decisions rather than an internal department name.

France: what separates accreditation and personal approval?

L. 6221-1 concerns accreditation across examination phases; L. 1131-3 separately concerns ABM-approved practitioners. Neither document automatically supplies the other role.

Prepare the records

Julie’s legal research currently covers French law. The Swiss sections prepare documents; they do not establish Swiss-law product capability.

Use masked references. Nothing is sent before your explicit continuation.

Synthetic example

Laboratory-analysis-site and permission-scope matrix

Laboratory
Synthetic L1; legal holder E1 unresolved
Site
S1; permission/site match unknown
Analyses
A1 version 2; methods/phases not checked
Leadership
Masked P1; qualifications and title unassessed
Accreditation
Q1; actual scope not supplied
Outsourcing
X1; laboratory/provider and country unresolved
Records
T1; application/change/reporting acts incomplete

This record organises supplied documents and values; it certifies no entitlement, permission or safety.

Laboratory-analysis-site and permission-scope matrix
Document questionReference and records to compare

France: which foreign analytical branch is identified?

L. 1131-2-1 distinguishes the EU/EEA declaration route with recognised equivalent conditions and otherwise authorisation after verification. It is not automatic acceptance of every foreign laboratory.

Switzerland: which activity needs the federal file?

LAGH 28 and OAGH concern medical cytogenetic/molecular-genetic analyses in the stated branch. Screening programmes under article 30 remain a separate permission task.

Switzerland: how are accreditation and director evidence connected?

OAGH 9–17 separates accredited activity, the qualified pending-accreditation branch, laboratory leadership/deputy and actual permission scope. No eligibility or technical competence is inferred here.

Switzerland: what identifies outsourced analytical work?

OAGH 14 asks for actual laboratories/providers, accreditation status/scope and analyses or steps. Domestic outsourcing and foreign handoff under LAGH 29/OAGH 28 have different records.

Switzerland: which changes require separate tracking?

OAGH 26 distinguishes advance director/site and specified activity notices from the thirty-day provider-change branch. Keep actual event and notice rather than one universal deadline.

Switzerland: what belongs to the annual activity report?

OAGH 27 requires the previous calendar year’s analyses/methods, outsourced laboratory/provider information and quality-control summary by end June. The register organises supplied figures without certifying the report.

Frequently asked questions

France: which holder, authority and site are distinguished?

L. 1131-2-1 addresses the laboratory/health-establishment holder; R. 1131-14 identifies ARS, analysis categories and exercise site. Record actual decisions rather than an internal department name.

France: which foreign analytical branch is identified?

L. 1131-2-1 distinguishes the EU/EEA declaration route with recognised equivalent conditions and otherwise authorisation after verification. It is not automatic acceptance of every foreign laboratory.

Switzerland: what identifies outsourced analytical work?

OAGH 14 asks for actual laboratories/providers, accreditation status/scope and analyses or steps. Domestic outsourcing and foreign handoff under LAGH 29/OAGH 28 have different records.

Switzerland: what belongs to the annual activity report?

OAGH 27 requires the previous calendar year’s analyses/methods, outsourced laboratory/provider information and quality-control summary by end June. The register organises supplied figures without certifying the report.

Sources and versions

  1. ch-gumg-fr

    2025-08-01

  2. ch-oagh-fr
  3. fr-csp-L1131-2-1
  4. fr-csp-L1131-3
  5. fr-csp-L6221-1
  6. fr-csp-R1131-14